+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Batten Disease Market by Product, Type of Disease, Route of Administration, End-User - Global Forecast 2025-2030- Product Image
Batten Disease Market by Product, Type of Disease, Route of Administration, End-User - Global Forecast 2025-2030- Product Image
Sale

Batten Disease Market by Product, Type of Disease, Route of Administration, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6015113
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Batten Disease Market grew from USD 54.89 million in 2023 to USD 57.61 million in 2024. It is expected to continue growing at a CAGR of 5.18%, reaching USD 78.19 million by 2030.

Batten Disease, a rare and fatal neurodegenerative disorder affecting children, is part of a group of disorders known as neuronal ceroid lipofuscinoses. The scope of understanding Batten Disease involves deep dives into genetic mutations, enzyme deficiencies, and progressive neural damage. The market necessity for Batten Disease diagnostics and therapeutics is imperative due to its severely debilitating nature, with a lack of curative treatments heightening demand for symptom relief and potentially curative interventions. Application areas primarily include early diagnostic genetic testing, enzyme replacement therapies, and emerging gene therapies, while key end-users encompass hospitals, specialized neurology clinics, and genetic research institutions. Market growth is spurred by advancements in genetic engineering and increased awareness facilitated by advocacy groups, highlighting the importance of early diagnosis and potential preemptive treatment strategies. Development of gene therapies like enzyme replacement represents promising growth opportunities, with collaborations between biotech entities and research organizations being pivotal. Biopharmaceutical research is crucial, especially in terms of novel therapeutic pathways aiming to delay disease progression. However, challenges include high costs and lengthy development timelines for novel therapies, regulatory hurdles, and the limited understanding of pathogenesis due to the rarity of the disorder, impacting drug development incentives. Furthermore, ethical concerns surrounding gene therapy research could impede market growth. To harness market potential, innovation should focus on early genetic diagnostics, enhanced carrier screening, and patient-specific treatment regimens. Collaborations between academia and industry can accelerate translational research and clinical trial initiatives. The market nature is niche but features opportunities for broad impact via breakthroughs in personalized medicine and genetic therapy landscapes. Hence, companies investing in robust R&D and strategic partnerships are likely positioned to make substantial inroads into addressing Batten Disease and similar neurodegenerative disorders, ultimately expanding their market footprint.

Understanding Market Dynamics in the Batten Disease Market

The Batten Disease Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increased awareness and diagnosis of batten disease
    • Rising investment in rare disease research
    • Improvement in healthcare infrastructure and access
  • Market Restraints
    • Limited clinical trial data and regulatory challenges
  • Market Opportunities
    • Development of innovative therapeutics
    • Advancements in genomic research and personalized medicine
  • Market Challenges
    • Complexity of disease and treatment development

Exploring Porter’s Five Forces for the Batten Disease Market

Porter’s Five Forces framework further strengthens the insights of the Batten Disease Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Batten Disease Market

External macro-environmental factors deeply influence the performance of the Batten Disease Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Batten Disease Market

The Batten Disease Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Batten Disease Market

The Batten Disease Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Batten Disease Market

The Batten Disease Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Batten Disease Market, highlighting leading vendors and their innovative profiles. These include Abeona Therapeutics Inc., Alexion Pharmaceuticals Inc., Amicus Therapeutics, BioMarin Pharmaceutical Inc., Denali Therapeutics, Neurogene Inc., Novartis AG, Orchard Therapeutics, Passage Bio, Inc., Regenxbio Inc., and Teva Pharmaceuticals Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Batten Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Drugs
      • Cerliponase Alfa
      • Levetiracetam
      • Valproic Acid
    • Gene Therapy
  • Type of Disease
    • Adult Neuronal Ceroid Lipofuscinosis
    • Infantile Neuronal Ceroid Lipofuscinosis
    • Juvenile Neuronal Ceroid Lipofuscinosis
    • Late Infantile Neuronal Ceroid Lipofuscinosis
  • Route of Administration
    • Intravenous
    • Intraventricular
    • Oral
  • End-User
    • Homecare Settings
    • Hospitals
    • Research Institutions
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased awareness and diagnosis of batten disease
5.1.1.2. Rising investment in rare disease research
5.1.1.3. Improvement in healthcare infrastructure and access
5.1.2. Restraints
5.1.2.1. Limited clinical trial data and regulatory challenges
5.1.3. Opportunities
5.1.3.1. Development of innovative therapeutics
5.1.3.2. Advancements in genomic research and personalized medicine
5.1.4. Challenges
5.1.4.1. Complexity of disease and treatment development
5.2. Market Segmentation Analysis
5.2.1. Product: Rising significance of cerliponase alfa in treatment
5.2.2. End-User: Diverse scope of applications in hospital settings
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Batten Disease Market, by Product
6.1. Introduction
6.2. Drugs
6.2.1. Cerliponase Alfa
6.2.2. Levetiracetam
6.2.3. Valproic Acid
6.3. Gene Therapy
7. Batten Disease Market, by Type of Disease
7.1. Introduction
7.2. Adult Neuronal Ceroid Lipofuscinosis
7.3. Infantile Neuronal Ceroid Lipofuscinosis
7.4. Juvenile Neuronal Ceroid Lipofuscinosis
7.5. Late Infantile Neuronal Ceroid Lipofuscinosis
8. Batten Disease Market, by Route of Administration
8.1. Introduction
8.2. Intravenous
8.3. Intraventricular
8.4. Oral
9. Batten Disease Market, by End-User
9.1. Introduction
9.2. Homecare Settings
9.3. Hospitals
9.4. Research Institutions
9.5. Specialty Clinics
10. Americas Batten Disease Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Batten Disease Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Batten Disease Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Latus Bio, Inc. secures USD 54 million series a funding to revolutionize CNS gene therapy with precision targeting and safer dosing
13.3.2. University of Rochester medical center bolsters efforts in battling batten disease with USD 5.7 million NINDS funding to accelerate gene therapy trials
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. BATTEN DISEASE MARKET RESEARCH PROCESS
FIGURE 2. BATTEN DISEASE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BATTEN DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BATTEN DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BATTEN DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL BATTEN DISEASE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL BATTEN DISEASE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS BATTEN DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS BATTEN DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES BATTEN DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES BATTEN DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC BATTEN DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC BATTEN DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BATTEN DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BATTEN DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. BATTEN DISEASE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. BATTEN DISEASE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BATTEN DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BATTEN DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BATTEN DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BATTEN DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BATTEN DISEASE MARKET DYNAMICS
TABLE 7. GLOBAL BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BATTEN DISEASE MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BATTEN DISEASE MARKET SIZE, BY CERLIPONASE ALFA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BATTEN DISEASE MARKET SIZE, BY LEVETIRACETAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BATTEN DISEASE MARKET SIZE, BY VALPROIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BATTEN DISEASE MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BATTEN DISEASE MARKET SIZE, BY ADULT NEURONAL CEROID LIPOFUSCINOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BATTEN DISEASE MARKET SIZE, BY INFANTILE NEURONAL CEROID LIPOFUSCINOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BATTEN DISEASE MARKET SIZE, BY JUVENILE NEURONAL CEROID LIPOFUSCINOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BATTEN DISEASE MARKET SIZE, BY LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BATTEN DISEASE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BATTEN DISEASE MARKET SIZE, BY INTRAVENTRICULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BATTEN DISEASE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BATTEN DISEASE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BATTEN DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BATTEN DISEASE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BATTEN DISEASE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BATTEN DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. CANADA BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 46. CANADA BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 47. CANADA BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 48. CANADA BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. MEXICO BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 51. MEXICO BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. MEXICO BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BATTEN DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC BATTEN DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. CHINA BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. CHINA BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 73. CHINA BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 74. CHINA BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. CHINA BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. INDIA BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. INDIA BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 78. INDIA BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 79. INDIA BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. INDIA BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. JAPAN BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. JAPAN BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 88. JAPAN BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 89. JAPAN BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. JAPAN BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. THAILAND BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 118. THAILAND BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 119. THAILAND BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. THAILAND BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BATTEN DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. DENMARK BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 134. DENMARK BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 135. DENMARK BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. DENMARK BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. EGYPT BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 139. EGYPT BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 140. EGYPT BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. EGYPT BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. FINLAND BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. FINLAND BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 144. FINLAND BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 145. FINLAND BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. FINLAND BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. FRANCE BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 149. FRANCE BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 150. FRANCE BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. FRANCE BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. GERMANY BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 154. GERMANY BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 156. GERMANY BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. ITALY BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. ITALY BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 164. ITALY BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 165. ITALY BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. ITALY BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. NORWAY BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. NORWAY BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 179. NORWAY BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 180. NORWAY BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. NORWAY BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. POLAND BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. POLAND BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 184. POLAND BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 185. POLAND BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. POLAND BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. QATAR BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 189. QATAR BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 190. QATAR BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. QATAR BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. SPAIN BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 209. SPAIN BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 210. SPAIN BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. SPAIN BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. TURKEY BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 224. TURKEY BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. TURKEY BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM BATTEN DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM BATTEN DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM BATTEN DISEASE MARKET SIZE, BY TYPE OF DISEASE, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM BATTEN DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM BATTEN DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. BATTEN DISEASE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 238. BATTEN DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Batten Disease Market, which are profiled in this report, include:
  • Abeona Therapeutics Inc.
  • Alexion Pharmaceuticals Inc.
  • Amicus Therapeutics
  • BioMarin Pharmaceutical Inc.
  • Denali Therapeutics
  • Neurogene Inc.
  • Novartis AG
  • Orchard Therapeutics
  • Passage Bio, Inc.
  • Regenxbio Inc.
  • Teva Pharmaceuticals Industries Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 57.61 Million
Forecasted Market Value ( USD ) by 2030 $ 78.19 Million
Compound Annual Growth Rate5.1%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Batten Disease - Pipeline Insight, 2024 - Product Image

Batten Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Batten Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Batten Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 139 Pages
  • Global
From
Addison's Disease Treatment Market by Drug Class, Diagnosis, Treatments, Distribution Channel, Route of Administration - Global Forecast 2025-2030 - Product Image

Addison's Disease Treatment Market by Drug Class, Diagnosis, Treatments, Distribution Channel, Route of Administration - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Thyroid Eye Disease Treatments Market by Drug, Route of Administration, Treatment, Diagnosis, Distribution - Global Forecast 2025-2030 - Product Image

Thyroid Eye Disease Treatments Market by Drug, Route of Administration, Treatment, Diagnosis, Distribution - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Antidiabetics Market Size, Share & Trends Analysis Report by Drug Class (GLP-1 Receptor Agonists, Insulin), Type (Type 1, Type 2), Route of Administration (Oral, Intravenous), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Antidiabetics Market Size, Share & Trends Analysis Report by Drug Class (GLP-1 Receptor Agonists, Insulin), Type (Type 1, Type 2), Route of Administration (Oral, Intravenous), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.